Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 3

SJR OA
CiteScore
Impact Factor

Therapeutics and Clinical Risk Management

ISSN: 1178-203X


       

Archive: Volume 3, 2007


Effect of patient-specific factors on weekly warfarin dose

Heather P Whitley, Joli D Fermo, Elinor CG Chumney, Walter Adam Brzezinski

Therapeutics and Clinical Risk Management 2007, 3:499-504

Published Date: 15 July 2007

The use of antithrombotics in patients presenting with stroke and atrial fibrillation

Carl Burgess, Tristram Ingham, Martin Woodbridge, Mark Weatherall, Michael Nowitz

Therapeutics and Clinical Risk Management 2007, 3:491-498

Published Date: 15 July 2007

Detection and remediation of medically urgent situations using telemedicine case management for older patients with diabetes mellitus

Roberto Izquierdo, Suzanne Meyer, Justin Starren, Robin Goland, Jeanne Teresi, et al

Therapeutics and Clinical Risk Management 2007, 3:485-489

Published Date: 15 July 2007

Creating diagnostic scores using data-adaptive regression: An application to prediction of 30-day mortality among stroke victims in a rural hospital in India

Merrill D Birkner, SP Kalantri, Vaishali Solao, Priya Badam, Rajnish Joshi, Ashish Goel, Madhukar Pai, Alan E Hubbard

Therapeutics and Clinical Risk Management 2007, 3:475-484

Published Date: 15 July 2007

Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy

Shimon Lecht, Simon Haroutiunian, Amnon Hoffman, Philip Lazarovici

Therapeutics and Clinical Risk Management 2007, 3:467-474

Published Date: 15 July 2007

Zanamivir for the prevention of influenza in adults and children age 5 years and older

Lea S Eiland, Edward H Eiland

Therapeutics and Clinical Risk Management 2007, 3:461-465

Published Date: 15 July 2007

Acute migraine: Current treatment and emerging therapies

Arun A Kalra, Debra Elliott

Therapeutics and Clinical Risk Management 2007, 3:449-459

Published Date: 15 July 2007

Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin

Serkan Öncü

Therapeutics and Clinical Risk Management 2007, 3:441-448

Published Date: 15 July 2007

Recombinant human epoetin beta in the treatment of renal anemia

Francesco Locatelli, Pietro Pozzoni, Lucia Del Vecchio

Therapeutics and Clinical Risk Management 2007, 3:433-439

Published Date: 15 July 2007

A review of the role of capecitabine in the treatment of colorectal cancer

Pasquale Comella

Therapeutics and Clinical Risk Management 2007, 3:421-431

Published Date: 15 July 2007

The safety and efficacy of alefacept in the treatment of chronic plaque psoriasis

Claudia Jenneck, Natalija Novak

Therapeutics and Clinical Risk Management 2007, 3:411-420

Published Date: 15 July 2007

Tramadol extended-release in the management of chronic pain

Bill McCarberg

Therapeutics and Clinical Risk Management 2007, 3:401-410

Published Date: 15 July 2007

Current approach to cancer pain management: Availability and implications of different treatment options

Hrachya Nersesyan, Konstantin V Slavin

Therapeutics and Clinical Risk Management 2007, 3:381-400

Published Date: 15 July 2007

A review of rabeprazole in the treatment of acid-related diseases

Fabio Pace, Stefano Pallotta, Stefania Casalini, Gabriele Bianchi Porro

Therapeutics and Clinical Risk Management 2007, 3:363-379

Published Date: 15 July 2007

Editorial || FREE PAPER ||

Garry M Walsh

Therapeutics and Clinical Risk Management 2007, 3:361-362

Published Date: 15 July 2007